Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05309031 · ClinicalTrials.gov registry record · NA
An Immersion Intervention for Symptoms of PTSD in Student Veterans
A NA study of Stress Disorders, Post-Traumatic, sponsored by University of Nevada, Las Vegas.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT05309031: Completed NA study of Stress Disorders, Post-Traumatic, sponsored by University of Nevada, Las Vegas.
NCT05309031 is a NA study of Stress Disorders, Post-Traumatic that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 13 participants, below the 156-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05309031, a NA study of Stress Disorders, Post-Traumatic, has completed, sponsored by University of Nevada, Las Vegas.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will explore the physical and psychological effects of warm water immersion to the chest on student Veterans who experience symptoms of Post-Traumatic Stress Disorder (PTSD) and may also have depression, anxiety and pain.
Primary Outcome
Salivary alpha-amylase samples will be analyzed by Salametrics, Carlsbad, CA using a Saliva Bio Oral Swab device and Swab Storage Tube, immediately placed on ice and frozen within 2 hours at -70 degrees. Frozen sample aliquots containing at least 325µL, will be shipped at one time, on dry ice for analysis using .25 µL, by a Kinetic Reaction assay, with a sensitivity of 0.4 U/ml, range of 2 - 400 U/ml. Samples are run in duplicate.
Conditions Studied
Interventions
- OTHER Water Immersion
Study Locations (1)
Nevada
- UNLV - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT05309031 record still lists
NCT05309031 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 156-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Water Immersion is the first listed.
NCT05309031 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT05309031 about?
NCT05309031 is a clinical study titled "An Immersion Intervention for Symptoms of PTSD in Student Veterans". This study will explore the physical and psychological effects of warm water immersion to the chest on student Veterans who experience symptoms of Post-Traumatic Stress Disorder (PTSD) and may also have depression, anxiety and pain.
What is the current status of trial NCT05309031?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2022-10-01. Estimated completion is 2023-12-31.
What conditions does trial NCT05309031 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT05309031?
The interventions under investigation include: Water Immersion (OTHER).
Who is sponsoring clinical trial NCT05309031?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05309031 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05309031's enrollment target sits among peer trials
13 65th of 66 higher than 2 of 66 other Stress Disorders, Post-Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
-
Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI